Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Filipovich

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Advances in Pediatrics|January 1, 1983
Bone marrow transplantation in pediatricsW Krivit, N K Ramsay, W Woods, et al.
Transplantation|March 1, 1985
Allogeneic bone marrow transplantation with related donors other than HLA MLC-matched siblings, and the use of antithymocyte globulin, prednisone, and methotrexate for prophylaxis of graft-versus-host diseaseA H Filipovich, N K Ramsay, D C Arthur, et al.
Blood|July 1, 1992
Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficienciesA H Filipovich, R S Shapiro, N K Ramsay, et al.
Transplantation|June 1, 1985
Pretransplant conditioning with busulfan (Myleran) and cyclophosphamide for nonmalignant diseases. Assessment of engraftment following histocompatible allogeneic bone marrow transplantationB R Blazar, N K Ramsay, J H Kersey, et al.
Lancet (London, England)|June 5, 1982
Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantationA H Filipovich, P B McGlave, N K Ramsay, et al.
Blood|November 15, 1992
Circulating cytomegalovirus (CMV) neutralizing activity in bone marrow transplant recipients: comparison of passive immunity in a randomized study of four intravenous IgG products administered to CMV-seronegative patientsA H Filipovich, M H Peltier, M K Bechtel, et al.
Lancet (London, England)|March 3, 1984
Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host diseaseA H Filipovich, D A Vallera, R J Youle, et al.
British Journal of Haematology|May 1, 1985
Graft-versus-host disease prophylaxis with anti-T-cell monoclonal antibody OKT3, prednisone and methotrexate in allogeneic bone-marrow transplantationA H Filipovich, C L Krawczak, J H Kersey, et al.
Transplantation|August 1, 1986
Allogeneic bone marrow transplantation for X-linked lymphoproliferative syndromeA H Filipovich, B R Blazar, N K Ramsay, et al.
Seminars in Oncology|June 1, 1985
Bone marrow transplantation for acute lymphocytic leukemiaM E Nesbit, W G Woods, D Weisdorf, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Advances in Pediatrics|January 1, 1983
Bone marrow transplantation in pediatricsW Krivit, N K Ramsay, W Woods, et al.
Transplantation|March 1, 1985
Allogeneic bone marrow transplantation with related donors other than HLA MLC-matched siblings, and the use of antithymocyte globulin, prednisone, and methotrexate for prophylaxis of graft-versus-host diseaseA H Filipovich, N K Ramsay, D C Arthur, et al.
Blood|July 1, 1992
Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficienciesA H Filipovich, R S Shapiro, N K Ramsay, et al.
Transplantation|June 1, 1985
Pretransplant conditioning with busulfan (Myleran) and cyclophosphamide for nonmalignant diseases. Assessment of engraftment following histocompatible allogeneic bone marrow transplantationB R Blazar, N K Ramsay, J H Kersey, et al.
Lancet (London, England)|June 5, 1982
Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantationA H Filipovich, P B McGlave, N K Ramsay, et al.
Blood|November 15, 1992
Circulating cytomegalovirus (CMV) neutralizing activity in bone marrow transplant recipients: comparison of passive immunity in a randomized study of four intravenous IgG products administered to CMV-seronegative patientsA H Filipovich, M H Peltier, M K Bechtel, et al.
Lancet (London, England)|March 3, 1984
Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host diseaseA H Filipovich, D A Vallera, R J Youle, et al.
British Journal of Haematology|May 1, 1985
Graft-versus-host disease prophylaxis with anti-T-cell monoclonal antibody OKT3, prednisone and methotrexate in allogeneic bone-marrow transplantationA H Filipovich, C L Krawczak, J H Kersey, et al.
Transplantation|August 1, 1986
Allogeneic bone marrow transplantation for X-linked lymphoproliferative syndromeA H Filipovich, B R Blazar, N K Ramsay, et al.
Seminars in Oncology|June 1, 1985
Bone marrow transplantation for acute lymphocytic leukemiaM E Nesbit, W G Woods, D Weisdorf, et al.
Pageof 10